Efficacy and Safety Evaluation of Azimilide Dihydrochloride in Patients With Implantable Cardioverter Defibrillators

NCT00035490 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

633

Enrollment

INDUSTRY

Sponsor class

Conditions

Arrhythmia

Interventions

DRUG: Azimilide Dihydrochloride
DRUG: placebo
DRUG: Azimilide Dihydrochloride

Sponsor

Forest Laboratories